elements
Transforming Spine Surgery Through Personalized Solutions
Our mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. The Carlsmed aprevo® personalized surgery platform is designed to improve the standard of care for spine surgery one patient at a time.
Technology Platform
A fully integrated, end-to-end platform for personalized spinal care.
Data-driven 3D surgical planning and visualization, precision alignment, and optimized fit.
Advancing What’s Possible Through Personalized Spinal Solutions
Each device is tailored to the individual patient – explore why patients want personalized care and how it makes a difference.
aprevo® Portfolio
Personalized surgical procedures
Learn more
3D visualization
Learn more
A foundation built on data
Learn more
Latest Investor News
July 22, 2026
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2026 financial results after market close on
Read More →May 5, 2026
Carlsmed® Reports First Quarter 2026 Financial Results
First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company
Read More →April 28, 2026
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
CARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and Chief Executive Officer, will participate in the following investor conferences.
Read More →
Contact Us
Learn about our personalized procedural solutions.
Contact Us
Patient Support
Learn about your personalized procedure.
Learn More
aprevo® is FDA-cleared in the U.S. for lumbar and cervical spinal fusion indications only.